Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Nippon Kayaku launches infliximab biosimilar in Japan

Dec. 1, 2014

Lilly patent describes prostanoid EP4 receptor antagonists

Nov. 28, 2014

Small-molecule MIF inhibitors tested in the collagen-induced arthritis mouse model

Nov. 25, 2014

CHMP backs Otezla for psoriasis and psoriatic arthritis

Nov. 24, 2014

Activity of novel PEGylated anti-IL-17A aptamer tested in models of rheumatoid arthritis

Nov. 21, 2014

Janssen files MAA for Simponi in severe active non-radiographic axial spondyloarthritis

Nov. 20, 2014

Clinical benefit on rheumatoid arthritis demonstrated in phase I trial of FPA-008

Nov. 20, 2014

Preclinical pharmacology, safety and activity profiling of dual JAK3/ITK inhibitor ARN-4079

Nov. 19, 2014

Chong Kun Dang Holdings patent divulges novel HDAC6 inhibitors

Nov. 19, 2014

INV-17 demonstrates safety and therapeutic activity in a model of rheumatoid arthritis

Nov. 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.